EcoDrugPlus

Tachykinin Receptor 3-Like

Ensembl ID : ENSOJAG00000000477
Gene Symbol: TACR3L
1 Cross references
218 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSOJAG00000014866
Gene Symbol: TERT
1 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSOJAG00000006173
Gene Symbol: TBXAS1
1 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSOJAG00000024135
Gene Symbol: TBXA2R
1 Cross references
192 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSOJAG00000016292
Gene Symbol: TYMP
1 Cross references
172 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSOJAG00000015137
Gene Symbol: TYMS
1 Cross references
223 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSOJAG00000008635
Gene Symbol: TRHR
1 Cross references
201 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor B

Ensembl ID : ENSOJAG00000017728
Gene Symbol: TRHRB
1 Cross references
193 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSOJAG00000013562
Gene Symbol: TLR7
1 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSOJAG00000013556
Gene Symbol: TLR8
1 Cross references
187 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSOJAG00000006138
Gene Symbol: TAAR1
1 Cross references
393 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSOJAG00000006283
Gene Symbol: TAAR1
1 Cross references
378 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).